To probe into the association between HIC1 expression and immunotherapeutic responses, we utilized the ROC Plotter database, which included data on gastric cancer patients treated with immunotherapy, specifically anti‐PD‐1(pembrolizumab) agents. The gene discussed is HIC1; the disease is gastric cancer.